ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al
ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, THE UNIVERSITY OF SHEFFIELD and MSD INTERNATIONAL BUSINESS GMBH |
NATCO PHARMA LIMITED and NATCO PHARMA INC. |
3:2023cv00796 |
February 10, 2023 |
US District Court for the District of New Jersey |
Tonianne J Bongiovanni |
Zahid N Quraishi |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on March 9, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 11 STIPULATION AND ORDER granting request for Extension of Time to Answer, Move or otherwise respond to the Complaint. The time by which the Defendants are required to answer or otherwise respond to the Complaint is extended through and including 4/17/2023. Signed by Magistrate Judge Tonianne J. Bongiovanni on 3/9/2023. (mlh) |
Filing 10 Letter from Charles H. Chevalier, Esq. to the Honorable Tonianne J. Bongiovanni, U.S.M.J.. (Attachments: #1 Text of Proposed Order)(CHEVALIER, CHARLES) |
Filing 9 NOTICE of Appearance by JAMES S. RICHTER on behalf of NATCO PHARMA INC., NATCO PHARMA LIMITED (RICHTER, JAMES) |
Filing 8 SUMMONS ISSUED as to NATCO PHARMA INC., NATCO PHARMA LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kht) |
Filing 7 AO120 Patent/Trademark Form filed. (kht) |
Magistrate Judge Tonianne J. Bongiovanni added. (kht) |
Filing 6 Corporate Disclosure Statement by THE UNIVERSITY OF SHEFFIELD. (CHEVALIER, CHARLES) |
Filing 5 Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) |
Filing 4 Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) |
Filing 3 Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) |
Filing 2 Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) |
Filing 1 COMPLAINT against NATCO PHARMA INC., NATCO PHARMA LIMITED ( Filing and Admin fee $ 402 receipt number ANJDC-14024738), filed by THE UNIVERSITY OF SHEFFIELD, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet, #5 Local Civil Rule 11.2 Certification)(CHEVALIER, CHARLES) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.